The Claim
In symptomatic Alzheimer’s disease, accelerated atrophy of the precuneus and inferior parietal cortex is strongly associated with progressive decline in cognitive function over time.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with symptomatic Alzheimer’s disease, faster shrinkage of the precuneus and inferior parietal cortex regions of the brain is linked to a steady worsening of memory and thinking abilities over time.
See the scientific wording
In symptomatic Alzheimer’s disease stages, accelerated atrophy of the precuneus and inferior parietal cortex is strongly associated with worsening cognitive function over time, suggesting these regions become critical biomarkers for monitoring disease progression in later stages.
Tau proteins clump together inside brain cells in the memory center, then spread to the back part of the brain, killing cells and shrinking tissue. This shrinkage in the back of the brain directly causes worsening memory, attention, and thinking skills.
What the research says
1 studyStudy: Disease stage-specific atrophy markers in Alzheimer’s disease
When people with Alzheimer’s start having memory and thinking problems, their brain’s thinking areas (precuneus and inferior parietal cortex) shrink faster, and this shrinking is linked to their symptoms getting worse. Tracking this shrinkage over time helps doctors see how the disease is progressing.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.